IL140630A0 - Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins - Google Patents
Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteinsInfo
- Publication number
- IL140630A0 IL140630A0 IL14063099A IL14063099A IL140630A0 IL 140630 A0 IL140630 A0 IL 140630A0 IL 14063099 A IL14063099 A IL 14063099A IL 14063099 A IL14063099 A IL 14063099A IL 140630 A0 IL140630 A0 IL 140630A0
- Authority
- IL
- Israel
- Prior art keywords
- isolated
- peptides derived
- envelope proteins
- cytoplasmic tail
- viral envelope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11254498A | 1998-07-09 | 1998-07-09 | |
PCT/IB1999/001261 WO2000002909A2 (en) | 1998-07-09 | 1999-07-08 | Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL140630A0 true IL140630A0 (en) | 2002-02-10 |
Family
ID=22344479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14063099A IL140630A0 (en) | 1998-07-09 | 1999-07-08 | Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1093519A2 (en) |
JP (1) | JP2003533165A (en) |
AU (2) | AU4386999A (en) |
CA (1) | CA2333855A1 (en) |
IL (1) | IL140630A0 (en) |
WO (1) | WO2000002909A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020064520A1 (en) * | 1999-08-19 | 2002-05-30 | Yanina Rozenberg | Targeted artificial gene delivery |
US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2512792A (en) * | 1991-08-30 | 1993-04-05 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Defective interfering hiv particles with chimeric cd4-env |
EP0746625B1 (en) * | 1992-11-09 | 2004-03-31 | THE UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Targetable vector particles |
US5940307A (en) * | 1994-12-14 | 1999-08-17 | The Trustees Of Columbia University In The City Of New York | Method for predicting the tendency of a protein to form amphiphilic αβ structure |
AUPN861496A0 (en) * | 1996-03-13 | 1996-04-04 | Commonwealth Scientific And Industrial Research Organisation | Lytic peptides |
-
1999
- 1999-07-08 CA CA002333855A patent/CA2333855A1/en not_active Abandoned
- 1999-07-08 JP JP2000559138A patent/JP2003533165A/en active Pending
- 1999-07-08 IL IL14063099A patent/IL140630A0/en unknown
- 1999-07-08 WO PCT/IB1999/001261 patent/WO2000002909A2/en not_active Application Discontinuation
- 1999-07-08 AU AU43869/99A patent/AU4386999A/en not_active Abandoned
- 1999-07-08 EP EP99926703A patent/EP1093519A2/en not_active Withdrawn
-
2003
- 2003-08-13 AU AU2003235023A patent/AU2003235023A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2003533165A (en) | 2003-11-11 |
AU2003235023A1 (en) | 2003-09-11 |
AU4386999A (en) | 2000-02-01 |
CA2333855A1 (en) | 2000-01-20 |
EP1093519A2 (en) | 2001-04-25 |
WO2000002909A2 (en) | 2000-01-20 |
WO2000002909A3 (en) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8828598A (en) | Retrovirus and viral vectors | |
HUP0102478A3 (en) | Particles of hcv envelope proteins: use for vaccination | |
AU6591998A (en) | Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein | |
AU3826899A (en) | Peptide analogues of pacap | |
ZA9811316B (en) | Novel hepatitis C virus NS5B protein | |
HUP0002472A3 (en) | Isolated dendritic cell membrane protein genes | |
AU1606800A (en) | Membrane transport proteins | |
AU3990799A (en) | Viral characterization by direct detection of capsid proteins | |
HK1046911A1 (en) | Stabilized viral envelope proteins and uses thereof | |
EP1100545A4 (en) | Regulated expression of recombinant proteins using rna viruses | |
AU5652396A (en) | Glucose-inducible recombinant viral vector | |
IL140630A0 (en) | Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins | |
AU9105698A (en) | Rab proteins | |
AU2241699A (en) | Expression of proteolytically-sensitive peptides | |
AU4558799A (en) | Methods and compositions for generating recombinant adeno-associated virus vectors | |
AU7471098A (en) | Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents | |
IL139016A0 (en) | Retroviral vectors including modified envelope escort proteins | |
AU5563699A (en) | Analogs of udp-murnac peptides, assays and kits | |
AU6301698A (en) | Anti-hiv peptides and proteins | |
AU5681598A (en) | Liposomes comprising peptide antigens derived from x protein of hepatitis b virus | |
AU1536999A (en) | Modified sv40 viral vectors | |
FI973371A0 (en) | An isolated peptide | |
ZA992569B (en) | Separation of air. | |
GB9811171D0 (en) | Viral vector | |
ZA200007318B (en) | Particles of HCV envelope proteins: use for vaccination. |